Pages that link to "Q41031893"
Jump to navigation
Jump to search
The following pages link to Malignant effusions contain lysophosphatidic acid (LPA)-like activity (Q41031893):
Displaying 50 items.
- Dual regulation of lysophosphatidic acid (LPA1) receptor signalling by Ral and GRK (Q24308869) (← links)
- Disaggregation and invasion of ovarian carcinoma ascites spheroids (Q25257559) (← links)
- The emerging role of lysophosphatidic acid in cancer (Q28191543) (← links)
- Lysophosphatidic acid synthesis and release (Q28609420) (← links)
- Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis (Q30489645) (← links)
- Role of malignant ascites on human mesothelial cells and their gene expression profiles (Q33559857) (← links)
- Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions (Q33585979) (← links)
- Association of lipid metabolism with ovarian cancer (Q34171997) (← links)
- Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists (Q34225947) (← links)
- Sphingosine 1-phosphate: synthesis and release (Q34233389) (← links)
- Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management. (Q34233431) (← links)
- Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer (Q34517736) (← links)
- Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis (Q34685562) (← links)
- Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer (Q34785252) (← links)
- Lysophosphatidic acid in vascular development and disease (Q35018207) (← links)
- Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment (Q35098085) (← links)
- Molecular mechanisms of lysophosphatidic acid action (Q35559631) (← links)
- Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review (Q35581662) (← links)
- Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity (Q35828524) (← links)
- Dielectrophoretic differentiation of mouse ovarian surface epithelial cells, macrophages, and fibroblasts using contactless dielectrophoresis (Q35903105) (← links)
- Lysophosphatidic Acid disrupts junctional integrity and epithelial cohesion in ovarian cancer cells (Q35942558) (← links)
- Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis (Q36016449) (← links)
- A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. (Q36063011) (← links)
- Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma (Q36065252) (← links)
- Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells (Q36127217) (← links)
- Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells (Q36177654) (← links)
- LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study (Q36181402) (← links)
- Tumor microenvironment: what can effusions teach us? (Q36293063) (← links)
- Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. (Q36321148) (← links)
- Altered gene and protein expression by Nm23-H1 in metastasis suppression (Q36445269) (← links)
- Inhibition of lysophosphatidic acid receptor-2 expression by RNA interference decreases lysophosphatidic acid-induced urokinase plasminogen activator activation, cell invasion, and migration in ovarian cancer SKOV-3 cells (Q36609335) (← links)
- Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer (Q36616823) (← links)
- A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome (Q36929682) (← links)
- Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression (Q36970728) (← links)
- Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling (Q37139302) (← links)
- Clinical-translational approaches to the Nm23-H1 metastasis suppressor (Q37242266) (← links)
- Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury (Q37433301) (← links)
- Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression (Q37486804) (← links)
- S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac. (Q37699403) (← links)
- The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells (Q37711207) (← links)
- Targeting the heparin-binding epidermal growth factor-like growth factor in ovarian cancer therapy (Q37802152) (← links)
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer (Q39169603) (← links)
- Lysophosphatidic acid and sphingosine-1-phosphate promote morphogenesis and block invasion of prostate cancer cells in three-dimensional organotypic models (Q39458550) (← links)
- Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation (Q39713485) (← links)
- LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites (Q39897898) (← links)
- Signal transduction mechanisms involved in the proliferation of C6 glioma cells induced by lysophosphatidic acid (Q40370649) (← links)
- Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers (Q40395023) (← links)
- Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells (Q40399464) (← links)
- Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1. (Q40609797) (← links)
- Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer (Q41552639) (← links)